They went on to test PDA tumor slices with the combination of immune checkpoint inhibitor programmed cell death (PD-1) and C-X-C chemokine receptor 4 receptor blockade, showing that the drugs significantly enhanced reactivation of the endogenous CD8+ T cell antitumor function [57]. This evidence concerns the gene CD8A and neoplasm.